Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364375128> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4364375128 endingPage "146" @default.
- W4364375128 startingPage "141" @default.
- W4364375128 abstract "Englisch: Being one of the most common genetic neurodegenerative disease, Huntington's disease has been a model disease - also for gene therapy. Among the various options, the development of antisense oligonucleotides is the most advanced. Further options at the RNA level include micro-RNAs and modulators of RNA processing (splicing), at the DNA level zinc finger proteins. Several products are in clinical trials. These differ in their mode of application and in the extent of systemic availability. Another important difference between therapeutic strategies could be whether all forms of the huntingtin protein are targeted in the same extent, or whether a therapy preferentially targets particular toxic forms such as the exon1 protein. The results of the recently terminated GENERATION HD1 trial were somewhat sobering, most likely due to the side effect-related hydrocephalus. Therefore they represent just one step towards the development of an effective gene therapy against Huntington's disease.Deutsch: Als häufige genetisch bedingte neurodegenerative Erkrankung ist die Huntington-Krankheit eine Modellerkrankung – auch für die Gentherapie. Unter den unterschiedlichen Möglichkeiten ist die Entwicklung von Antisense-Oligonukleotiden am weitesten fortgeschritten. Als weitere Optionen auf Ebene der RNA stehen Mikro-RNAs und Modulatoren der RNA-Prozessierung (Spleißen) zur Verfügung, auf DNA-Ebene Zink-Finger-Proteine. Mehrere Produkte befinden sich in der klinischen Prüfung. Diese unterscheiden sich in Applikationsform und systemischer Verfügbarkeit, aber auch in der genauen Wirkung. Ein wichtiger Unterschied könnte darin liegen, ob alle Formen des Huntingtin-Proteins gleichermaßen von der Therapie angesprochen werden, oder ob sich die Therapie präferentiell gegen besonders toxische Formen wie das Exon1-Protein richtet. Die Ergebnisse der kürzlich abgebrochenen GENERATION HD1 Studie waren etwas ernüchternd, am ehesten aufgrund der nebenwirkungsbedingten Liquorzirkulationsstörung. Sie sind daher nur ein Schritt in der Entwicklung zu einer wirksamen Gentherapie gegen die Huntington-Krankheit." @default.
- W4364375128 created "2023-04-12" @default.
- W4364375128 creator A5028305178 @default.
- W4364375128 creator A5055137091 @default.
- W4364375128 date "2023-04-01" @default.
- W4364375128 modified "2023-10-01" @default.
- W4364375128 title "Gentherapie der Huntington-Krankheit" @default.
- W4364375128 cites W1986475550 @default.
- W4364375128 cites W2012024892 @default.
- W4364375128 cites W2027833699 @default.
- W4364375128 cites W2118546680 @default.
- W4364375128 cites W2124660038 @default.
- W4364375128 cites W2148709530 @default.
- W4364375128 cites W2154300427 @default.
- W4364375128 cites W2162229008 @default.
- W4364375128 cites W2291779372 @default.
- W4364375128 cites W2609055977 @default.
- W4364375128 cites W2749718288 @default.
- W4364375128 cites W2782442390 @default.
- W4364375128 cites W2922179566 @default.
- W4364375128 cites W2949587997 @default.
- W4364375128 cites W2953448192 @default.
- W4364375128 cites W3005113700 @default.
- W4364375128 cites W3029880661 @default.
- W4364375128 cites W3033067723 @default.
- W4364375128 cites W3034741813 @default.
- W4364375128 cites W3035876159 @default.
- W4364375128 cites W3042128387 @default.
- W4364375128 cites W3123809922 @default.
- W4364375128 cites W3194986424 @default.
- W4364375128 cites W3211430529 @default.
- W4364375128 cites W3211762579 @default.
- W4364375128 cites W4207011933 @default.
- W4364375128 cites W4210446393 @default.
- W4364375128 cites W4210584483 @default.
- W4364375128 cites W4221115405 @default.
- W4364375128 cites W4226267344 @default.
- W4364375128 cites W4282979939 @default.
- W4364375128 cites W4285164848 @default.
- W4364375128 doi "https://doi.org/10.1055/a-2042-2338" @default.
- W4364375128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37040787" @default.
- W4364375128 hasPublicationYear "2023" @default.
- W4364375128 type Work @default.
- W4364375128 citedByCount "0" @default.
- W4364375128 crossrefType "journal-article" @default.
- W4364375128 hasAuthorship W4364375128A5028305178 @default.
- W4364375128 hasAuthorship W4364375128A5055137091 @default.
- W4364375128 hasBestOaLocation W43643751281 @default.
- W4364375128 hasConcept C104317684 @default.
- W4364375128 hasConcept C111599444 @default.
- W4364375128 hasConcept C153911025 @default.
- W4364375128 hasConcept C54355233 @default.
- W4364375128 hasConcept C71924100 @default.
- W4364375128 hasConcept C86803240 @default.
- W4364375128 hasConceptScore W4364375128C104317684 @default.
- W4364375128 hasConceptScore W4364375128C111599444 @default.
- W4364375128 hasConceptScore W4364375128C153911025 @default.
- W4364375128 hasConceptScore W4364375128C54355233 @default.
- W4364375128 hasConceptScore W4364375128C71924100 @default.
- W4364375128 hasConceptScore W4364375128C86803240 @default.
- W4364375128 hasIssue "04" @default.
- W4364375128 hasLocation W43643751281 @default.
- W4364375128 hasLocation W43643751282 @default.
- W4364375128 hasOpenAccess W4364375128 @default.
- W4364375128 hasPrimaryLocation W43643751281 @default.
- W4364375128 hasRelatedWork W1963861474 @default.
- W4364375128 hasRelatedWork W1967492928 @default.
- W4364375128 hasRelatedWork W1983335647 @default.
- W4364375128 hasRelatedWork W2028721360 @default.
- W4364375128 hasRelatedWork W2048934768 @default.
- W4364375128 hasRelatedWork W2050858497 @default.
- W4364375128 hasRelatedWork W2070952754 @default.
- W4364375128 hasRelatedWork W2233754051 @default.
- W4364375128 hasRelatedWork W2358155881 @default.
- W4364375128 hasRelatedWork W2379266697 @default.
- W4364375128 hasVolume "91" @default.
- W4364375128 isParatext "false" @default.
- W4364375128 isRetracted "false" @default.
- W4364375128 workType "article" @default.